Pharma IQ | 06/07/2016
As the UK preps to make its decision on whether to retain its EU membership, many are pondering what chain reactions could lie in wait behind either choice. Especially as the United Kingdom’s pharma and life science industries are keystones for Europe. According to statistics from BMI Research, last year the UK earned the second largest amount of pharmaceutical sales within the EU single market. (1) Pharma and Cold Chain IQ explores the varying views and predictions on the potential outcom...
To continue reading this story Click Here
RECOMMENDED
Upcoming Events
Pharmaceutical Launch Excellence Summit
2 - 3 December, 2025
UK
Register Now |
View Agenda |
Learn More